Latest Share Price Performance News

4DMedical Limited reported a 56% jump in FY2025 operating revenue driven by SaaS growth, while narrowing its net loss to $30.1 million. The company also secured $13.9 million in capital and a $10 million funding facility to accelerate product commercialisation.

FOS Capital Limited reported a strong 47.5% increase in net profit for FY2025 alongside a modest revenue rise, announcing a 1 cent final dividend payable in October.

Wagners Holding Company Limited reported a 120% increase in net profit after tax for FY25 despite a 10.4% revenue decline, driven by strong segment performance and cost management. The company also declared a higher fully franked final dividend of 3.2 cents per share.

Corporate Travel Management Limited has delayed its FY25 financial results due to potential revenue recognition adjustments in Europe, prompting a voluntary ASX trading suspension.

Nuix Limited reported a slight revenue increase to $221.5 million for FY25 but swung to a net loss of $9.2 million, weighed down by rising legal fees and restructuring costs. The company’s AI-driven Nuix Neo platform showed strong contract growth, while cash EBITDA improved significantly.

Regis Resources Limited delivered a strong FY25 with record revenue and net profit, becoming debt-free and declaring a dividend, while advancing its underground growth strategy. However, its McPhillamys Gold Project faces a significant legal hurdle following a heritage protection declaration.

Trading in Aspermont Limited shares has resumed following the ASX's immediate lifting of the suspension after the company released a key announcement.

AIC Mines Limited reported a robust FY25 with $189.6 million revenue and $15 million net profit, securing key contracts and funding for its Eloise expansion and Jericho development.

HMC Capital Limited reported a record FY25 profit of $265.2 million, driven by strategic acquisitions and growth in digital infrastructure and energy transition sectors. The company also declared a consistent dividend and strengthened its balance sheet with an increased undrawn debt facility.

Rhythm Biosciences has launched a $3.75 million placement alongside an offer of over 52 million new options, all contingent on shareholder approval. The move aims to bolster working capital as the company advances its cancer diagnostic products.

Magnetite Mines Limited has announced a pro rata renounceable rights issue to raise up to $2.65 million, aiming to advance its flagship Razorback iron ore project in South Australia. The offer includes free attaching options and is partially underwritten, reflecting the company’s strategic push towards securing funding and completing key project milestones.

Kincora Copper Limited advances its project generator model with six asset-level partnerships unlocking over A$110 million in funding, supported by a C$4 million private placement led by prominent North American investors. The company ramps up drilling and exploration activities, particularly at its 100% owned Condobolin project.